Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Naxos Resources (NAXOF) -- Ignore unavailable to you. Want to Upgrade?

To: Paul Salber who wrote (9244)	2/26/1998 7:50:00 AM
From: Max Haber	Read Replies (2) \| Respond to of 20681

Alas, another Wednesday come and gone. Perhaps next week. Now that we it the 20 days mark, for the five day turnaround on assays, we must be getting close. The only good thing about the delays are more of my shares are hitting the 12 and 18 month time frame for preferential capital gains treatment . Yesterday I again wondered why I bought into Naxos. I reviewed some of the information that got me started. I took a look at the annual reports of some of the majors like Newmont, Placer Dome, Homestake,Stillwater, Getchell Gold even the chart and "reports of the "B" stock. Looking at the size of their ore bodies, the grades they are averaging its amazing. Most of the majors average .06 to .33 oz/ton. Ore bodies much smaller than the potential of Naxos. The B**-, the market pushed that (embarresment to the mining industry) stock from $4 to over $200 in nine months on BS assays less than (small number) you look it up. Naxos with assays being done by three or four recognized labs could capture a lot of attention from the mining community in a very short period of time on a good report. If Naxos can recover 1/10th of the assays they reported on January 12th it could be real sweet. More confirmation of the precious metals at Franklin Lake are necessary for the stock to get the additional following that I'm looking for. It will be interesting to compare the next set of results, assays, against the assays of the other majors with billion dollar market caps. IMHO the next report will be pivotal. In the meantime tic-tock-tic-tock-tic-tock-tic-tock. I was here two years ago, I'll be here next week. Max Haber